pharma news today obesity drug glp-1 drugs such as semaglutide and tirzepatide are transforming and diabetes care in India, but experts warn that improper use could lead to significant muscle loss. A new India-specific consensus highlights Pharma Giants Bet on Next-Generation

Chu SY, Callaghan WM, Kim SY, Schmid CH, Lau J, England LJ, et al

Diabetes type 2 has a high prevalence in the obese (BMI 25kg/m 2 ) and overweight (BMI 30kg/m 2 ) population, and these patients tend to have poor diets and sedentary lifestyles

Looking for quick, painless results that start showing in as little as 24 hours? Most of the promotions are from beauticians offering the treatment, but Lemon Bottle makes similar bold claims on its own official channels

The study received ethical approval from the Regional and Institutional Committee of Science and Research Ethics of the Scientific Council of Health (ETT TUKEB 15032/2019/EKU) and was conducted in adherence to the principles of the Declaration of Helsinki